{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:52:31Z","timestamp":1761663151048},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2013,8,6]],"date-time":"2013-08-06T00:00:00Z","timestamp":1375747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s12072-013-9455-y","type":"journal-article","created":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T14:20:00Z","timestamp":1375712400000},"page":"790-799","source":"Crossref","is-referenced-by-count":11,"title":["Hard clinical outcomes in patients with NAFLD"],"prefix":"10.1007","volume":"7","author":[{"given":"Ramesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,6]]},"reference":[{"key":"9455_CR1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1872-034X.2011.00824.x","volume":"41","author":"AJ Sanyal","year":"2011","unstructured":"Sanyal AJ. NASH: a global health problem. Hepatol Res 2011;41:670\u2013674","journal-title":"Hepatol Res"},{"key":"9455_CR2","unstructured":"AmarapurkarDN, Hashimoto E, Lesmana LA, et al. Asia-Pacific Working Party on NAFLD. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol 2007;22:788\u2013793"},{"key":"9455_CR3","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0016-5085(19)33218-4","volume":"63","author":"DB McGill","year":"1972","unstructured":"McGill DB, Humpherys SR, Baggenstoss AH, et al. Cirrhosis and death after jejunoileal shunt. Gastroenterology 1972;63:872\u2013877","journal-title":"Gastroenterology"},{"key":"9455_CR4","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.23527","volume":"51","author":"MS Ascha","year":"2010","unstructured":"Ascha MS, Hanouneh IA, Lopez R, et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010;51:1972\u20131978","journal-title":"Hepatology"},{"key":"9455_CR5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","author":"LA Adams","year":"2005","unstructured":"Adams LA, Lymp JF, Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129:113\u2013121","journal-title":"Gastroenterology"},{"key":"9455_CR6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/gut.2011.237974","volume":"60","author":"VW Wong","year":"2011","unstructured":"Wong VW, Wong GL, Tsang SW, et al. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut 2011;60:829\u2013836","journal-title":"Gut"},{"key":"9455_CR7","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.22845","volume":"49","author":"A Gastaldelli","year":"2009","unstructured":"Gastaldelli A, Kozakova M, Hojlund K, et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 2009;49:1537\u20131544","journal-title":"Hepatology"},{"key":"9455_CR8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s12032-007-0034-8","volume":"24","author":"A Bilici","year":"2007","unstructured":"Bilici A, Ozguroglu M, Mihmanli I, Turna H, Adaletli I. A case\u2013control study of non-alcoholic fatty liver disease in breast cancer. Med Oncol 2007;24:367\u2013371","journal-title":"Med Oncol"},{"key":"9455_CR9","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s10620-011-2006-2","volume":"57","author":"MR Pagadala","year":"2012","unstructured":"Pagadala MR, Zein CO, Dasarathy S, et al. Prevalence of hypothyroidism in nonalcoholic fatty liver disease. Dig Dis Sci 2012;57:528\u2013534","journal-title":"Dig Dis Sci"},{"key":"9455_CR10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2036.2011.04579.x","volume":"33","author":"A Baranova","year":"2011","unstructured":"Baranova A, Tran TP, Birerdinc A, Younossi ZM. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2011;33:801\u2013814","journal-title":"Aliment Pharmacol Ther"},{"key":"9455_CR11","doi-asserted-by":"crossref","unstructured":"Loria P, Lonardo A, Lombardini S, et al. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors. J Gastroenterol Hepatol 2005;20:1176\u20131184","DOI":"10.1111\/j.1440-1746.2005.03924.x"},{"key":"9455_CR12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1478-3231.2011.02623.x","volume":"32","author":"MV Machado","year":"2012","unstructured":"Machado MV, Gon\u00e7alves S, Carepa F, et al. Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease. Liver Int 2012;32:241\u2013248","journal-title":"Liver Int"},{"key":"9455_CR13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/lt.22004","volume":"16","author":"K Yalamanchili","year":"2010","unstructured":"Yalamanchili K, Saadeh S, Klintmalm GB, et al. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. Liver Transpl 2010;16:431\u2013439","journal-title":"Liver Transpl"},{"key":"9455_CR14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jcp.55.9.689","volume":"55","author":"CD Evans","year":"2002","unstructured":"Evans CD, Oien KA, Mac Sween RN, et al. Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury? J Clin Pathol 2002;55:689\u2013692","journal-title":"J Clin Pathol"},{"key":"9455_CR15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2009.03.019","volume":"51","author":"CK Argo","year":"2009","unstructured":"Argo CK, Northup PG, Al-Osaimi AM, et al. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol 2009;51:371\u2013379","journal-title":"J Hepatol"},{"key":"9455_CR16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/gut.2009.205088","volume":"59","author":"VW Wong","year":"2010","unstructured":"Wong VW, Wong GL, Choi PC, et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3\u00a0years. Gut 2010;59:969\u2013974","journal-title":"Gut"},{"key":"9455_CR17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2008.06.018","volume":"49","author":"JP Ong","year":"2008","unstructured":"Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver related mortality in non-alcoholic fatty liver disease. J Hepatol 2008;49:608\u2013612","journal-title":"J Hepatol"},{"key":"9455_CR18","first-page":"2101","volume":"50","author":"P Jepsen","year":"2003","unstructured":"Jepsen P, Vilstrup H, Mellemkjaer L, et al. Prognosis of patients with a diagnosis of fatty liver\u2014a registry-based cohort study. Hepatogastroenterology 2003;50:2101\u20132104","journal-title":"Hepatogastroenterology"},{"key":"9455_CR19","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413\u20131419","journal-title":"Gastroenterology"},{"key":"9455_CR20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.23314","volume":"51","author":"C S\u00f6derberg","year":"2010","unstructured":"S\u00f6derberg C, St\u00e5l P, Askling J, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010;51:595\u2013602","journal-title":"Hepatology"},{"key":"9455_CR21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","volume":"43","author":"G Musso","year":"2011","unstructured":"Musso G, Gambino R, Cassader M, et al. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43:617\u2013649","journal-title":"Ann Med"},{"key":"9455_CR22","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/gut.2003.019984","volume":"53","author":"S Dam-Larsen","year":"2004","unstructured":"Dam-Larsen S, Franzmann M, Andersen IB, et al. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 2004;53:750\u2013755","journal-title":"Gut"},{"key":"9455_CR23","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/hep.1840220616","volume":"22","author":"MR Teli","year":"1995","unstructured":"Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995;22:1714\u20131719","journal-title":"Hepatology"},{"key":"9455_CR24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","volume":"7","author":"N Rafiq","year":"2009","unstructured":"Rafiq N, Bai C, Fang Y, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009;7:234\u2013238","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9455_CR25","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","volume":"53","author":"ZM Younossi","year":"2011","unstructured":"Younossi ZM, Stepanova M, Rafiq N, et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology 2011;53:1874\u20131882","journal-title":"Hepatology"},{"key":"9455_CR26","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ajg.2010.18","volume":"105","author":"LA Adams","year":"2010","unstructured":"Adams LA, Harmsen S, Sauver JL, et al. Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. Am J Gastroenterol 2010;105:1567\u20131573","journal-title":"Am J Gastroenterol"},{"key":"9455_CR27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/hep.21103","volume":"43","author":"AJ Sanyal","year":"2006","unstructured":"Sanyal AJ, Banas C, Sargent C, et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 2006;43:682\u2013689","journal-title":"Hepatology"},{"key":"9455_CR28","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3748\/wjg.v11.i12.1848","volume":"11","author":"H Volzke","year":"2005","unstructured":"Volzke H, Robinson DM, Kleine V, et al. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 2005;11:1848\u20131853","journal-title":"World J Gastroenterol"},{"key":"9455_CR29","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/ajg.2009.238","volume":"104","author":"SY Choi","year":"2009","unstructured":"Choi SY, Kim D, Kim HJ, et al. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am J Gastroenterol 2009;104:1953\u20131960","journal-title":"Am J Gastroenterol"},{"key":"9455_CR30","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.2337\/diacare.27.10.2498","volume":"27","author":"G Targher","year":"2004","unstructured":"Targher G, Bertolini L, Padovani R, et al. Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. Diabetes Care 2004;27:2498\u20132500","journal-title":"Diabetes Care"},{"key":"9455_CR31","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.atherosclerosis.2008.09.012","volume":"204","author":"HC Kim","year":"2009","unstructured":"Kim HC, Kim D, Huh KB. Association between nonalcoholic fatty liver disease and carotid intima media thickness according to the presence of metabolic syndrome. Atherosclerosis 2009;204:521\u2013525","journal-title":"Atherosclerosis"},{"key":"9455_CR32","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2008.06.012","volume":"49","author":"S Sookoian","year":"2008","unstructured":"Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 2008;49:600\u2013607","journal-title":"J Hepatol"},{"key":"9455_CR33","doi-asserted-by":"crossref","first-page":"E282","DOI":"10.1152\/ajpendo.00604.2005","volume":"291","author":"R Lautamaki","year":"2006","unstructured":"Lautamaki R, Borra R, Iozzo P, et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 2006;291:E282\u2013E290","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"865\u2013873","key":"9455_CR34","first-page":"873","volume":"44","author":"M Ekstedt","year":"2006","unstructured":"Ekstedt M, Franz\u00e9n LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44(865\u2013873):873","journal-title":"Hepatology"},{"key":"9455_CR35","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2353\/ajpath.2006.051090","volume":"169","author":"S Cowey","year":"2006","unstructured":"Cowey S, Hardy RW. The metabolic syndrome: a high-risk state for cancer? Am J Pathol 2006;169:1505\u20131522","journal-title":"Am J Pathol"},{"key":"9455_CR36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.beem.2013.04.005","volume":"27","author":"H Boeing","year":"2013","unstructured":"Boeing H. Obesity and cancer\u2014the update 2013. Best Pract Res Clin Endocrinol Metab 2013;27:219\u2013227","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9455_CR37","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/bjc.2013.25","volume":"108","author":"WP Koh","year":"2013","unstructured":"Koh WP, Wang R, Jin A, et al. Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Br J Cancer 2013;108:1182\u20131188","journal-title":"Br J Cancer"},{"key":"9455_CR38","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625\u20131638","journal-title":"N Engl J Med"},{"key":"9455_CR39","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/jnci\/89.18.1360","volume":"89","author":"L Wideroff","year":"1997","unstructured":"Wideroff L, Gridley G, Mellemkjaer L, et al. Cancer incidence in a population based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997;89:1360\u20131365","journal-title":"J Natl Cancer Inst"},{"key":"9455_CR40","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1002\/cncr.24687","volume":"115","author":"AB Siegel","year":"2009","unstructured":"Siegel AB, Zhu AX. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer 2009;115:5651\u20135661","journal-title":"Cancer"},{"key":"9455_CR41","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","volume":"10","author":"DL White","year":"2012","unstructured":"White DL, Kanwal F, El-Serag HB. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol 2012;10:1342\u20131359","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9455_CR42","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00535-009-0112-0","volume":"44","author":"N Kawada","year":"2009","unstructured":"Kawada N, Imanaka K, Kawaguchi T, et al. Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis. J Gastroenterol 2009;44:1190\u20131194","journal-title":"J Gastroenterol"},{"key":"9455_CR43","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3748\/wjg.v16.i12.1436","volume":"16","author":"Y Takuma","year":"2010","unstructured":"Takuma Y, Nouso K. Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review. World J Gastroenterol 2010;16:1436\u20131441","journal-title":"World J Gastroenterol"},{"key":"9455_CR44","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.22734","volume":"49","author":"V Paradis","year":"2009","unstructured":"Paradis V, Zalinski S, Chelbi E, et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 2009;49:851\u2013859","journal-title":"Hepatology"},{"key":"9455_CR45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/bjs.8963","volume":"100","author":"F Cauchy","year":"2013","unstructured":"Cauchy F, Zalinski S, Dokmak S, et al. Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome. Br J Surg 2013;100:113\u2013121","journal-title":"Br J Surg"},{"key":"9455_CR46","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","volume":"51","author":"BQ Starley","year":"2010","unstructured":"Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010;51:1820\u20131832","journal-title":"Hepatology"},{"key":"9455_CR47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/cncr.21950","volume":"107","author":"RL Ahmed","year":"2006","unstructured":"Ahmed RL, Schmitz KH, Anderson KE, et al. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006;107:28\u201336","journal-title":"Cancer"},{"key":"9455_CR48","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/aje\/152.9.847","volume":"152","author":"TK Murphy","year":"2000","unstructured":"Murphy TK, Calle EE, Rodriguez C, et al. Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 2000;152:847\u2013854","journal-title":"Am J Epidemiol"},{"key":"9455_CR49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2796.2011.02377.x","volume":"270","author":"A Stadlmayr","year":"2011","unstructured":"Stadlmayr A, Aigner E, Steger B, et al. Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia. J Intern Med 2011;270:41\u201349","journal-title":"J Intern Med"},{"key":"9455_CR50","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/13651820701286177","volume":"9","author":"HA Pitt","year":"2007","unstructured":"Pitt HA. Hepato-pancreato-biliary fat: the good, the bad and the ugly. HPB (Oxford) 2007;9:92\u201397","journal-title":"HPB (Oxford)"},{"key":"9455_CR51","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2003.11.020","volume":"126","author":"A Lonardo","year":"2004","unstructured":"Lonardo A, Adinolfi LE, Loria P, et al. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 2004;126:586\u2013597","journal-title":"Gastroenterology"},{"key":"9455_CR52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7326\/0003-4819-133-8-200010170-00009","volume":"133","author":"SH Mehta","year":"2000","unstructured":"Mehta SH, Brancati FL, Sulkowski MS, et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000;133:59\u2013592","journal-title":"Ann Intern Med"},{"key":"9455_CR53","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2893.2004.00528.x","volume":"11","author":"C H\u00e9zode","year":"2004","unstructured":"H\u00e9zode C, Roudot-Thoraval F, Zafrani ES, et al. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections. J Viral Hepat 2004;11:455\u2013458","journal-title":"J Viral Hepat"},{"key":"9455_CR54","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0168-8278(02)00299-4","volume":"37","author":"J Westin","year":"2002","unstructured":"Westin J, Nordlinder H, Lagging M, et al. Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients. J Hepatol 2002;37:837\u2013842","journal-title":"J Hepatol"},{"key":"9455_CR55","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1053\/jhep.2001.24432","volume":"33","author":"LE Adinolfi","year":"2001","unstructured":"Adinolfi LE, Gambardella M, Andreana A, et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001;33:1358\u20131364","journal-title":"Hepatology"},{"key":"9455_CR56","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/cncr.11427","volume":"97","author":"K Ohata","year":"2003","unstructured":"Ohata K, Hamasaki K, Toriyama K, et al. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 2003;97:3036\u20133043","journal-title":"Cancer"},{"key":"9455_CR57","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.510250120","volume":"25","author":"S Naveau","year":"1997","unstructured":"Naveau S, Giraud V, Borotto E, et al. Excess weight risk factor for alcoholic liver disease. Hepatology 1997;25:108\u2013111","journal-title":"Hepatology"},{"key":"9455_CR58","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/jhep.2002.31782","volume":"35","author":"B Raynard","year":"2002","unstructured":"Raynard B, Balian A, Fallik D, et al. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 2002;35:635\u2013638","journal-title":"Hepatology"},{"key":"9455_CR59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cld.2007.02.007","volume":"11","author":"AD Clouston","year":"2007","unstructured":"Clouston AD, Jonsson JR, Powell EE. Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others. Clin Liver Dis 2007;11:173\u2013189","journal-title":"Clin Liver Dis"},{"key":"9455_CR60","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.dld.2010.01.016","volume":"42","author":"E Vanni","year":"2010","unstructured":"Vanni E, Bugianesi E, Kotronen A, et al. From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 2010;42:320\u2013330","journal-title":"Dig Liver Dis"},{"key":"9455_CR61","doi-asserted-by":"crossref","unstructured":"Park SK, Seo MH, Shin HC, et al. The clinical availability of non-alcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-years\u2019 prospective cohort study. Hepatology 2012. doi: 10.1002\/hep.26183","DOI":"10.1002\/hep.26183"},{"key":"9455_CR62","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1210\/er.2012-1009","volume":"34","author":"KH Williams","year":"2013","unstructured":"Williams KH, Shackel NA, Gorrell MD, et al. Diabetes and nonalcoholic fatty liver disease: a pathogenic duo. Endocr Rev 2013;34:84\u2013129","journal-title":"Endocr Rev"},{"key":"9455_CR63","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","volume":"126","author":"HB Serag El","year":"2004","unstructured":"El Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460\u2013468","journal-title":"Gastroenterology"},{"key":"9455_CR64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0032-1306426","volume":"32","author":"G Musso","year":"2012","unstructured":"Musso G, Olivetti C, Cassader M, et al. Obstructive sleep apnea\u2013hypopnea syndrome and nonalcoholic fatty liver disease: emerging evidence and mechanisms. Semin Liver Dis 2012;32:49\u201364","journal-title":"Semin Liver Dis"},{"key":"9455_CR65","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s00268-002-6321-9","volume":"26","author":"CA Redaelli","year":"2002","unstructured":"Redaelli CA, Wagner M, Krahenbuhl L, et al. Liver surgery in the era of tissue-preserving resections: early and late outcome in patients with primary and secondary hepatic tumors. World J Surg 2002;26:1126\u201332","journal-title":"World J Surg"},{"key":"9455_CR66","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1091-255X(98)80025-5","volume":"2","author":"KE Behrns","year":"1998","unstructured":"Behrns KE, Tsiotos GG, DeSouza NF, et al. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998;2:292\u2013298","journal-title":"J Gastrointest Surg"},{"key":"9455_CR67","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1072-7515(00)00261-1","volume":"191","author":"J Belghiti","year":"2000","unstructured":"Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 2000;191:38\u201346","journal-title":"J Am Coll Surg"},{"key":"9455_CR68","doi-asserted-by":"crossref","unstructured":"Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002;236:397\u2013406","DOI":"10.1097\/00000658-200210000-00001"},{"key":"9455_CR69","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.gassur.2003.09.012","volume":"7","author":"DA Kooby","year":"2003","unstructured":"Kooby DA, Fong Y, Suriawinata A, et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003;7:1034\u20131044","journal-title":"J Gastrointest Surg"},{"key":"9455_CR70","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","volume":"24","author":"JN Vauthey","year":"2006","unstructured":"Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065\u20132072","journal-title":"J Clin Oncol"},{"key":"9455_CR71","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1097\/00007890-200111270-00008","volume":"72","author":"CK Sun","year":"2001","unstructured":"Sun CK, Zhang XY, Zimmermann A, et al. Effect of ischemia reperfusion injury on the microcirculation of the steatotic liver of Zucker rat. Transplantation 2001;72:1625\u20131631","journal-title":"Transplantation"},{"key":"9455_CR72","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/00007890-199909270-00009","volume":"68","author":"AM Seifalian","year":"1997","unstructured":"Seifalian AM, Piasecki C, Agarwal A, et al. The effect of graded steatosis on the flow in the hepatic parenchymal microcirculation. Transplantation 1997;68:780\u2013784","journal-title":"Transplantation"},{"key":"9455_CR73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.510310108","volume":"31","author":"M Selzner","year":"2000","unstructured":"Selzner M, Clavien P-A. Failure of regeneration of the steatotic rat liver-disruption at two different levels of the regeneration pathway. Hepatology 2000;31:35\u201342","journal-title":"Hepatology"},{"key":"9455_CR74","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0041-1345(96)00158-3","volume":"29","author":"T Fukumori","year":"1997","unstructured":"Fukumori T, Ohkochi N, Tsukamoto S, et al. Why fatty liver is unsuitable for transplantation? Deterioration of mitochondrial ATP synthesis and sinusoidal structure during cold preservation of a liver with steatosis. Transplant Proc 1997;29:412\u2013415","journal-title":"Transplant Proc"},{"key":"9455_CR75","first-page":"1538","volume":"23","author":"R Adam","year":"1991","unstructured":"Adam R, Reynes M, Johann M, et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc 1991;23:1538\u20131540","journal-title":"Transplant Proc"},{"key":"9455_CR76","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-2001-12933","volume":"21","author":"M Selzner","year":"2001","unstructured":"Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001;21:105\u2013113","journal-title":"Semin Liver Dis"},{"key":"9455_CR77","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.TP.0000071205.52835.A4","volume":"76","author":"Y Soejima","year":"2003","unstructured":"Soejima Y, Shimada M, Suehiro T, et al. Use of steatotic graft in living-donor liver transplantation. Transplantation 2003;76:344\u2013348","journal-title":"Transplantation"},{"key":"9455_CR78","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/00007890-199611150-00011","volume":"62","author":"WA Marsman","year":"1996","unstructured":"Marsman WA, Wiesner RH, Rodriguez L, et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996;62:1246\u20131251","journal-title":"Transplantation"},{"key":"9455_CR79","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1053\/jlts.2003.50099","volume":"9","author":"D Verran","year":"2003","unstructured":"Verran D, Kusyk T, Painter D, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003;9:500\u2013505","journal-title":"Liver Transpl"},{"key":"9455_CR80","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0041-1345(98)01679-0","volume":"31","author":"M Hayashi","year":"1999","unstructured":"Hayashi M, Fujii T, Kiuchi K, et al. Effects of fatty infiltration of the graft on the outcome of living-related liver transplantation. Transplant Proc 1999;31:403","journal-title":"Transplant Proc"},{"key":"9455_CR81","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/lt.20340","volume":"11","author":"JY Cho","year":"2005","unstructured":"Cho JY, Suh KS, Know CH, et al. The hepatic regeneration power of mild steatotic grafts is not impaired in living-donor liver transplantation. Liver Transpl 2005;11:210\u2013217","journal-title":"Liver Transpl"},{"key":"9455_CR82","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00007890-199707270-00012","volume":"64","author":"TM Fishbein","year":"1997","unstructured":"Fishbein TM, Fiel MI, Emre S, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation 1997;64:248\u2013251","journal-title":"Transplantation"},{"key":"9455_CR83","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1600-6143.2009.02590.x","volume":"9","author":"SM Malik","year":"2009","unstructured":"Malik SM, deVera ME, Fontes P, et al. Outcome after liver transplantation for NASH cirrhosis. Am J Transplant 2009;9:782\u2013793","journal-title":"Am J Transplant"},{"key":"9455_CR84","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/lt.22198","volume":"17","author":"I Laish","year":"2011","unstructured":"Laish I, Braun M, Mor E, et al. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl 2011;17:15\u201322","journal-title":"Liver Transpl"},{"key":"9455_CR85","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/lt.21943","volume":"15","author":"SM Malik","year":"2009","unstructured":"Malik SM, Devera ME, Fontes P, et al. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis. Liver Transpl 2009;15:1843\u20131851","journal-title":"Liver Transpl"},{"key":"9455_CR86","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.transproceed.2004.07.003","volume":"36","author":"DS Sutedja","year":"2004","unstructured":"Sutedja DS, Gow PJ, Hubscher SG, et al. Revealing the cause of cryptogenic cirrhosis by posttransplant liver biopsy. Transpl Proc 2004;36:2334\u20132337","journal-title":"Transpl Proc"},{"key":"9455_CR87","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/bja\/85.1.91","volume":"85","author":"JP Adams","year":"2000","unstructured":"Adams JP, Murphy PG. Obesity in anaesthesia and intensive care. Br J Anaesth 2000;85:91\u2013108","journal-title":"Br J Anaesth"},{"key":"9455_CR88","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.24491","volume":"54","author":"N Bhala","year":"2011","unstructured":"Bhala N, Angulo P, van der Poorten D, et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology 2011;54:1208\u20131216","journal-title":"Hepatology"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-013-9455-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-013-9455-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-013-9455-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T12:22:36Z","timestamp":1596284556000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-013-9455-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,6]]},"references-count":88,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["9455"],"URL":"https:\/\/doi.org\/10.1007\/s12072-013-9455-y","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,6]]}}}